학술논문
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
Document Type
Article
Author
Goepfert, P.A.; Fu, B.; Bonaparte, M.I.; Haney, O.; Janosczyk, H.; Masotti, R.; Savarino, S.J.; Smith, J.; Gurunathan, S.; DiazGranados, C.A.; de Bruyn, G.; Chabanon, A.-L.; Davis, M.G.; Essink, B.J.; Frank, I.; Keefer, M.C.; Koutsoukos, M.; Schuerman, L.; Tavares-Da-Silva, F.; Kimmel, M.A.; Schwartz, H.; Sher, L.D.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, September 2021, 21(9):1257-1270)
Subject
Language
English
ISSN
14744457
14733099
14733099